Professor Robert Huddart is Professor of Urological Cancer at the Institute of Cancer Research. He completed a Master of Arts at Oxford, graduating in 1983 and a Bachelor of Medicine, Bachelor of Surgery at the University of London in 1986. He started specialist training in Clinical Oncology at the Royal Marsden Hospital in 1989. He was awarded the Frank Doyle and Rohan Williams medals in the examinations to become a Fellow of the Royal College of Radiologists. In 1992, he joined the ICR to complete a PhD in the molecular biology of testicular cancer with Professor Colin Cooper. After completing his oncology training in 1995 he was appointed Senior Lecturer and Honorary Consultant in Clinical Oncology at The Royal Marsden and The Institute of Cancer Research in 1995, made Reader in Urological Oncology in 2007 and Professor in in Urological Cancer in 2015.
He has a major research interest in improving the management of bladder cancer, particularly to improve conservative treatment in patients with muscle invasive bladder cancer. A major focus of his current work is the technical development of radiotherapy, including research on intensity-modulated and image-guided radiotherapy and the application of new imaging techniques. This is alongside work in selecting patients for conservative treatment, use of neoadjuvant and concomitant therapies. His second major research interests are in the management of testicular cancer with a focus on improving outcomes in high-risk disease, minimising toxicity in low-risk disease, work on survivorships issues and the genetics of testicular cancer.
He has served as Chair of the National Cancer Research Institute Testis CSG, is current chair of the localised Bladder cancer NCRI sub group and member of the Bladder CSG and CTrad. He jointly leads the MSc in Oncology course at the Institute of Cancer Research.